FAQs

Pharmacy Frequently Asked Questions

Showing FAQs for Pharmacy View all FAQs

  1. What is the “Bill To Ship To” model?

In a typical Bill To Ship To transaction, three persons are involved:

  • A – The person who places the order with B and instructs B to send the goods directly to C.
  • B – The person who supplies/sends the goods directly to C on behalf of A.
  • C – The recipient of the goods.
  1. How many supplies are involved in a Bill To Ship To transaction?

There are two supplies involved in the complete transaction. Accordingly, two tax invoices are required.

  1. Who issues the two tax invoices?

The invoices are:

Invoice 1:
B → A

Invoice 2:
A → C

  1. Who is responsible for generating the e-Way Bill?

For the movement of goods from B to C on behalf of A, either A or B can generate the e-Way Bill under the CGST Rules, 2017.

  1. Is more than one e-Way Bill required for the movement from B to C?

No. Only one e-Way Bill is required for the movement of goods from B to C in the Bill To Ship To transaction.

  1. What happens if B generates the e-Way Bill?

If B generates the e-Way Bill, the following details are required in Part A of GST FORM EWB-01:

Field

Details to be entered

Bill From

Details of B

Dispatch From

Actual place from where goods are dispatched; it may be the principal or additional place of business of B

Bill To

Details of A

Ship To

Address of C

Invoice Details

Details of Invoice-1 (B → A)

  1. What happens if A generates the e-Way Bill?

If A generates the e-Way Bill, the following details are required in Part A of GST FORM EWB-01:

Field

Details to be entered

Bill From

Details of A

Dispatch From

Actual place from where goods are dispatched; it may be the principal or additional place of business of B

Bill To

Details of C

Ship To

Address of C

Invoice Details

Details of Invoice-2 (A → C)

  1. Does the actual dispatch location have to belong to A?

No. Where the goods are physically dispatched by B, the Dispatch From location may be the principal or additional place of business of B.

  1. What is the key difference between the two cases?

The difference is who generates the e-Way Bill and which invoice details are reported:

  • If B generates the e-Way Bill → Invoice-1 (B → A) is reported.
  • If A generates the e-Way Bill → Invoice-2 (A → C) is reported.

In both cases, the physical movement is from B to C.

  1. What is the practical takeaway for a Bill To Ship To transaction?

The transaction involves:

Commercial flow:
B → A → C

Physical movement:
B → C

Invoices:

  1. B → A
  2. A → C

e-Way Bill:
Only one e-Way Bill, which can be generated by either A or B as per the prescribed procedure.

Source: Ministry of Finance / Press Information Bureau, clarification dated 23 April 2018, “Issues regarding ‘Bill To Ship To’ for e-Way Bill under CGST Rules, 2017.”

 

Question:
Whether formulations cleared have to be assessed to GST under the transferprice mechanism or on the basis of the MRP printed on them?

Answer:
The assessment of drugs and formulations under GST is generally based on the transaction value at each level of supply, and not on the MRP printed on the product.

GST follows an end-to-end Input Tax Credit (ITC) mechanism. Therefore, GST is charged on the actual transaction value between the supplier and recipient at each stage, subject to the valuation provisions under GST.

In simple terms:

GST Value = Transaction Value at the relevant stage of supply
Not = MRP printed on the formulation

For example:

Particulars

Amount

Manufacturer's transaction price to distributor

₹100

GST @ 12%

₹12

Distributor's purchase value

₹100

Distributor's sale price to retailer

₹120

GST @ 12%

₹14.40

Less: ITC

₹12

Net GST payable by distributor

₹2.40

Thus, MRP is not the basis for determining GST merely because it is printed on the formulation. MRP may become relevant for other regulatory/pricing purposes, but GST valuation ordinarily follows the transaction value, provided the conditions of Section 15 of the CGST Act are satisfied.

In the case of physician samples distributed free of cost, Input Tax Credit (ITC) availed on such samples is required to be reversed under Section 17(5)(h) of the WBGST Act, 2017, as goods disposed of by way of gifts or free samples are ineligible for ITC.

No GST is payable on the distribution of such physician samples free of cost, provided the transaction does not qualify as a supply under the GST law. However, the ITC reversal requirement must be complied with, wherever applicable.

Note: The statement that no tax is payable because the value of supply is zero should be used cautiously. Free distribution is not automatically outside the scope of supply in every circumstance.

 

No FAQs match your search.